Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep210 | Calcium and Bone | ECE2022

Hypercalcaemia induced acute pancreatitis

Abouzaid Mona , Anthony Sony

Introduction: Milk-alkali syndrome (MAS) consists of hypercalcemia, renal failure, and metabolic alkalosis as a result of ingestion of large amounts of calcium and absorbable alkali. Daily elemental calcium intake of no more than 2 g is considered safe. However, even doses lower than 2 g daily may result in hypercalcemia if additional predisposing factors are present. Vulnerable patients because of vomiting, diuretic use, and deviant eating habits. In these susceptible patient...

ea0031p388 | Thyroid | SFEBES2013

Myxedema Coma: an uncommon presentation of a common thyroid problem

Munir Atif , Hutchison Caroline , Kumar Balakrishna , Anthony Sony

Myxedema coma has very high mortality and should be suspected in an acutely unwell patient presenting with depressed mental status who is hypothermic, bradycardic and or hypotensive. Myxedema coma may be the first presentation of people with undiagnosed hypothyroidism. Definitive management is with thyroid hormone but supportive measures, identification and treatment of precipitating factors in an appropriately safe environment are vital. There is no consensus about preferred ...

ea0086p189 | Bone and Calcium | SFEBES2022

Denosumab induced recurrent, prolonged and life threatening hypocalcaemia

Tahir Chohan Muhammad , Olaremi Japhet , So Pye Dr , Sony Anthony Dr

Introduction: Denosumab, a human monoclonal antibody used in osteoporosis and second line treatment option for hypercalcaemia, can cause profound hypocalcaemia especially in Vitamin-D depleted and cancer patients.Case history: 56 years female, with diabetes, hypertension on metformin, empagliflozin, amlodipine and ramipril, presented with 3 months history of backache, no red flag signs, clinically and hemodynamically stable except mild confusion and spin...